Home > Healthcare > Medical Devices > Therapeutic Devices > Therapeutic Respiratory Devices Market

Therapeutic Respiratory Devices Market Size

  • Report ID: GMI696
  • Published Date: Jun 2023
  • Report Format: PDF

Therapeutic Respiratory Devices Market Size

Therapeutic Respiratory Devices Market size was worth more than USD 47 billion in 2022 and is poised to exhibit 4.7% CAGR from 2023 to 2032 driven by the rising prevalence of respiratory diseases globally.

 

In recent years, respiratory diseases have turned to be the major cause of mortality in both developing and underdeveloped nations. There has also been a rapid rise in the number of non-contagious respiratory disorders, such as asthma, COPD, cystic fibrosis, and lung cancer. As per the European Academy of Allergy and Clinical Immunology (EAACI) Global Atlas of Asthma 2022, more than 350 million people worldwide suffer from asthma. Furthermore, the rising levels of air pollution is increasing the burden of lung and respiratory ailments.

 

Therapeutic respiratory devices play a pivotal role in managing respiratory diseases, by providing much-needed relief and improving the quality of life for patients. These devices encompass a wide range of tools, including inhalers, nebulizers, positive airway pressure machines, and oxygen concentrators. Additionally, the advent of medically advanced respiratory devices has revolutionized the treatment of respiratory diseases for improved respiratory functions and enhanced overall well-being.

 

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Global market size for therapeutic respiratory devices was USD 47.2 billion in 2022 and is projected to record 4.7% CAGR by 2032 attributed to the high prevalence of respiratory diseases worldwide.

The inhalers product segment is expected to amass more than USD 40 billion by 2032 attributed to the increasing availability of newly developed automated inhalers.

North America therapeutic respiratory devices is set to exhibit growth at over 3.5% CAGR from 2023 to 2032 owing to the high frequency of respiratory disorders and the growing availability of modern healthcare infrastructure.

Some of the key therapeutic respiratory device providers include Hill-Rom Services Inc. (Baxter), ResMed Inc., Drägerwerk AG & Co. KGaA, Hamilton Medical, Koninklijke Philips N.V., VYAIRE MEDICAL, INC., Invacare Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., and Breas Medical AB

Therapeutic Respiratory Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 13
  • Tables & Figures: 625
  • Countries covered: 18
  • Pages: 330
 Download Free Sample